Apogee Therapeutics (APGE) CMO donates 8,000 shares to donor advised fund
Rhea-AI Filing Summary
Apogee Therapeutics, Inc. Chief Medical Officer Carl Dambkowski reported a bona fide gift of 8,000 shares of common stock on July 14, 2026. The shares were transferred to a donor advised fund, a non-market disposition recorded at $0.00 per share.
Following the gift, Dambkowski directly holds 169,873 shares of Apogee common stock. No open-market purchases or sales were reported in this insider transaction.
Positive
- None.
Negative
- None.
Insider Trade Summary
8,000 shares gifted
Mixed
1 txn
Insider
Dambkowski Carl
Role
Chief Medical Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Gift | Common Stock | 8,000 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 169,873 shares (Direct)
Footnotes (1)
- [object Object]
Key Figures
Shares gifted: 8,000 shares
Shares held after gift: 169,873 shares
Gift transaction price: $0.00 per share
+1 more
4 metrics
Shares gifted
8,000 shares
Bona fide gift of common stock on July 14, 2026
Shares held after gift
169,873 shares
Directly held by Carl Dambkowski following the reported transaction
Gift transaction price
$0.00 per share
Non-market transfer of shares to a donor advised fund
Gift transactions reported
1
Number of bona fide gift transactions in this Form 4
Key Terms
bona fide gift, donor advised fund, Common Stock
3 terms
bona fide gift regulatory
"This transaction involves a bona fide gift of securities"
A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.
donor advised fund financial
"gift of securities from the reporting person to a donor advised fund"
A donor advised fund is a charitable savings account you fund with cash or assets (including stocks) that lets you take an immediate tax benefit while recommending when and which charities receive grants over time. Think of it like a dedicated piggy bank for giving: you get tax relief when you put money in, can avoid selling appreciated securities and triggering capital gains, and still control the timing and recipients of donations, which affects tax planning, portfolio decisions, and public giving signals.
Common Stock financial
"security_title "Common Stock" reported in the transaction"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Apogee Therapeutics (APGE) report for Carl Dambkowski?
Apogee Therapeutics CMO Carl Dambkowski reported a bona fide gift of 8,000 shares of common stock. The shares were transferred to a donor advised fund, representing a non-market disposition rather than an open-market sale or purchase.
Was the Apogee Therapeutics (APGE) insider transaction a market sale?
No, the transaction was a bona fide gift, not a market sale. The 8,000 shares were transferred at $0.00 per share to a donor advised fund, indicating a charitable disposition rather than a sale for cash in the open market.
How many gift transactions are disclosed in this Apogee Therapeutics (APGE) Form 4?
The filing shows one gift transaction involving 8,000 shares of common stock. This single bona fide gift is the only transaction reported, with no accompanying purchases, sales, or derivative exercises in the same disclosure.